Market Size & Forecast
Current estimates place the global ADME Toxicology Testing Market at approximately USD 6.4 to USD 10.3 billion in 2024, depending on the data source. Forecasts suggest it will expand to well over USD 11 billion by 2030 and could even reach USD 30 billion by 2033—implying a robust compound annual growth rate in the double digits.
This growth is propelled by expanding pharmaceutical pipelines, rising chronic disease burdens, and increased outsourcing of pre‑clinical testing services to CROs.